Skip to main content
Equibles

PANAGORA ASSET MANAGEMENT INC

Position in RPRX — Royalty Pharma plc

CIK 883677 Boston, MA
Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$13,467,116
+$11,928,112 QoQ
Shares Held
240,184
+385.8% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#131
of 646 holders
Holding Since
Dec 2020
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PANAGORA ASSET MANAGEMENT INC holds $623,499,718 across 77 Biotechnology names. RPRX ranks #13 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 175,291 $109,300,950
2 INCY
Incyte Corp
 881,889 $99,970,937
3 XENE
Xenon Pharmaceuticals Inc.
 664,031 $40,080,911
4 MIRM
Mirum Pharmaceuticals, Inc.
 337,461 $39,506,559
5 TVTX
Travere Therapeutics, Inc.
 490,724 $27,878,030
6 JAZZ
Jazz Pharmaceuticals plc
 104,935 $25,286,186
7 RLAY
Relay Therapeutics, Inc.
 1,291,182 $24,158,015
8 CLDX
Celldex Therapeutics, Inc.
 572,538 $21,304,138

All Filings in RPRX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,467,116 240,184
2025-03-31 $1,539,004 49,438
2024-12-31 $1,624,068 63,664
2024-09-30 $1,785,664 63,120
2024-06-30 $1,664,474 63,120
2024-03-31 $5,846,164 192,498
2023-12-31 $7,893,711 281,015
2023-09-30 $1,787,793 65,873
2023-06-30 $1,516,957 49,348
2023-03-31 $1,778,008 49,348
2022-12-31 $1,247,646 31,570
2022-09-30 $2,035,438 50,658
2022-06-30 $4,917,965 116,983
2022-03-31 $442,702 11,363
2021-12-31 $452,815 11,363
2021-09-30 $410,658 11,363
2021-06-30 $568,162 13,861
2021-03-31 $676,458 15,508
2020-12-31 $358,307 7,159